|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03839 CPBIO
Nominal 
8.780 +0.030 (+0.343%) | 2026/06 - Interim USD(K$) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 34,331 | 11,285 | (16,062) | 5,629 |
| Net Cash from / (used in) Investing Activities | -- | (2,787) | (9,270) | (7,140) | (15,637) |
| Net Cash from / (used in) Financing Activities | -- | (24,383) | (7,073) | 30,225 | 10,385 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 7,161 | (5,058) | 7,023 | 377 |
| Cash & Cash Equivalents at beginning of period | -- | 32,381 | 37,606 | 30,859 | 31,093 |
| Effect of Foreign Exchange Rate Changes | -- | 289 | (167) | (276) | (611) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 39,831 | 32,381 | 37,606 | 30,859 |
| Remarks: | Real time quote last updated: 14/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 9,423 |
| %Change | -44.720% |
| EPS / (LPS) | USD 0.037 |
| NBV Per Share ($) | USD 1.220 |